Fetal myelomeningocele repair (FMMR) significantly impacts the clinical trajectory of infants born with spina bifida. This advanced intervention aims to protect neural tissue and reduce the incidence of myelomeningocele-associated hydrocephalus. Specifically, research indicates that successful in utero closure reverses hindbrain herniation. It also alters the developmental anatomy of the brain's third ventricle.

Improving Outcomes via Fetal Myelomeningocele Repair

Recent data analyzed the first 50 cases performed at major centers between 2019 and 2024. This retrospective review utilized prenatal fetal MRI and postnatal brain imaging to track anatomical shifts. Specifically, the study focused on the clivus-supraocciput angle (CSO) and third ventricle dimensions. Furthermore, clinicians stratified neonates into hydrocephalic and nonhydrocephalic groups for detailed comparative analysis.

Results showed a statistically significant difference in mean prenatal ventricle size between the two groups. Moreover, the postnatal clivus-supraocciput angle differed markedly between neonates requiring intervention and those who did not. Because FMMR reverses the herniation of the hindbrain, it creates a more favorable environment for subsequent endoscopic treatments. Consequently, endoscopic third ventriculostomy and choroid plexus cauterization (ETV/CPC) emerged as a viable alternative to traditional shunting.

The success rate for ETV/CPC in this cohort reached 70.6%. This high efficacy stems from the altered anatomy of the posterior fossa and third ventricle post-surgery. Therefore, FMMR serves as a cornerstone for improving neurosurgical outcomes. However, specialists recommend larger studies to confirm these findings and evaluate long-term brain development.

Frequently Asked Questions

How does FMMR help with hydrocephalus?

FMMR helps by reversing hindbrain herniation and altering the development of the third ventricle, which often reduces the need for traditional shunts.

What is the success rate of ETV/CPC after fetal surgery?

In this specific study, the success rate for ETV/CPC was 70.6%, suggesting it is a safe and effective alternative to ventriculoperitoneal shunts.

What anatomical markers are used to predict hydrocephalus?

Clinicians use prenatal ventricle size and the postnatal clivus-supraocciput (CSO) angle as key biometric markers to evaluate the risk of hydrocephalus.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider for any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.

References

Azouz H et al. Impact of fetal myelomeningocele repair on the clivus-supraocciput angle and third ventricle anatomy: evaluation of the outcome of endoscopic third ventriculostomy and choroid plexus cauterization. J Neurosurg Pediatr. 2026 May 15. doi: 10.3171/2025.12.PEDS25317. PMID: 42139738.

Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364(11):993-1004. doi:10.1056/NEJMoa1013623.

Farmer DL, Thom EA, Brock JW 3rd, et al. Management of Myelomeningocele Study Investigators. The Management of Myelomeningocele Study: full cohort 30-month pediatric outcomes. Am J Obstet Gynecol. 2018;218(2):256.e1-256.e13.